P209L mutation in Bag3 does not cause cardiomyopathy in mice

• Verfasst von: Fang, Xi [VerfasserIn]
• Verfasst von: Bogomolovas, Julius [VerfasserIn]
• Titel: P209L mutation in Bag3 does not cause cardiomyopathy in mice
• Verf.angabe: Xi Fang, Julius Bogomolovas, Paul Shichao Zhou, Yongxin Mu, Xiaolong Ma, Zee Chen, Lunfeng Zhang, Mason Zhu, Jennifer Veevers, Kunfu Ouyang, and Ju Chen
• Jahr: 2019
• Jahr des Originals: 2018
• Umfang: 8 S.
• Fussnoten: First published November 26, 2018 ; Gesehen am 19.11.2019
• Titel Quelle: Enthalten in: American journal of physiology
• Ort Quelle: Bethesda, Md. : APS, 1898
• Jahr Quelle: 2019
• Band/Heft Quelle: 316(2019), 2, Seite H392-H399
• ISSN Quelle: 2163-5773
• DOI: doi:10.1152/ajpheart.00714.2018
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1678024902

Abstract

Bcl-2-associated athanogene 3 (BAG3) is a cochaperone protein and a central player of the cellular protein quality control system. BAG3 is prominently expressed in the heart and plays an essential role in cardiac protein homeostasis by interacting with chaperone heat shock proteins (HSPs) in large, functionally distinct multichaperone complexes. The BAG3 mutation of proline 209 to leucine (P209L), which resides in a critical region that mediates the direct interaction between BAG3 and small HSPs (sHSPs), is associated with cardiomyopathy in humans. However, the mechanism by which the BAG3 P209L missense mutation leads to cardiomyopathy remains unknown. To determine the molecular basis underlying the cardiomyopathy caused by the BAG3 P209L mutation, we generated a knockin (KI) mouse model in which the endogenous Bag3 gene was replaced with mutant Bag3 containing the P215L mutation, which is equivalent to the human P209L mutation. We performed physiological, histological, and biochemical analyses of Bag3 P209L KI mice to determine the functional, morphological, and molecular consequences of the P209L mutation. We found that Bag3 P209L KI mice exhibited normal cardiac function and morphology up to 16 mo of age. Western blot analysis further revealed that levels of sHSPs, stress-inducible HSPs, ubiquitinated proteins, and autophagy were unaffected in P209L mutant mouse hearts. In conclusion, the P209L mutation in Bag3 does not cause cardiomyopathy in mice up to 16 mo of age under baseline conditions.NEW & NOTEWORTHY Bcl-2-associated athanogene 3 (BAG3) P209L mutation is associated with human cardiomyopathy. A recent study reported that transgenic mice overexpressing human BAG3 P209L in cardiomyocytes have cardiac dysfunction. In contrast, our P209L mice that express mutant BAG3 at the same level as that of wild-type mice displayed no overt phenotype. Our results suggest that human cardiomyopathy may result from species-specific requirements for the conserved motif that is disrupted by P209L mutation or from genetic background-dependent effects.